Immunotherapy and personalised medicine in review
Immunotherapy and personalised medicine in review
Treating childhood brainstem cancer using nanotechnology
Molecular drug imaging to guide brain cancer therapy
Complementary drug delivery techniques for interstitial administration
Editor's choice for January 2016
Subgroup analyses of METEOR; randomized phase III trial of cabozantinib vs everolimus for RCC
Discontinuing VEGF-targeted therapy for progression or toxicity affects outcomes of second-line therapies in mRCC
Molecular genetics of testicular cancer: What does the clinician need to know?
Actionable targets in patients with cisplatin-resistant advanced germ cell tumours
The DNA damage response
From genotype to molecular phenotype by proteomics
TAILORx: Genomic test helps identify low-risk women who do not need chemotherapy